$7.59
-0.22-2.82%
At close: -
$7.59
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Aurinia Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:AUPH | Benzinga
Aurinia Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 1
EPS Estimate
$0.110
Quarterly Revenue Estimate
$64.37M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$235.13M
Analyze the earnings history of Aurinia Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals | -$0.03 | $0.11 | — | — | $50.30M | $64.37M | — | — | 05/01/2025 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.19 | -$0.02 | $0.01 | 150.00% | $45.09M | $59.94M | $59.87M | -0.12% | 02/27/2025 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.09 | $0.01 | $0.10 | 900.00% | $54.52M | $57.69M | $67.77M | 17.47% | 11/07/2024 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.08 | $0.01 | $0.01 | 0.00% | $41.49M | $55.05M | $57.19M | 3.89% | 08/01/2024 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.18 | -$0.14 | -$0.03 | 78.57% | $34.41M | $47.45M | $50.30M | 6.01% | 05/02/2024 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.18 | -$0.16 | -$0.19 | -18.75% | $28.43M | $44.45M | $45.09M | 1.45% | 02/15/2024 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.06 | -$0.17 | -$0.09 | 47.06% | $55.78M | $38.50M | $54.52M | 41.60% | 11/02/2023 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.25 | -$0.20 | -$0.08 | 60.00% | $28.19M | $36.37M | $41.49M | 14.09% | 08/03/2023 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.27 | -$0.22 | -$0.18 | 18.18% | $21.63M | $27.87M | $34.41M | 23.46% | 05/04/2023 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.25 | -$0.27 | -$0.18 | 33.33% | $23.40M | $27.78M | $28.43M | 2.36% | 02/28/2023 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.39 | -$0.17 | -$0.06 | 64.71% | $14.67M | $36.18M | $55.78M | 54.17% | 11/03/2022 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.37 | -$0.22 | -$0.25 | -13.64% | $6.62M | $27.14M | $28.19M | 3.87% | 08/04/2022 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.40 | -$0.27 | -$0.27 | 0.00% | $914.00K | $19.76M | $21.63M | 9.44% | 05/10/2022 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.06 | — | -$0.25 | — | $50.03M | — | $23.40M | — | 02/28/2022 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.28 | -$0.33 | -$0.39 | -18.18% | $29.00K | $13.88M | $14.67M | 5.67% | 11/03/2021 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.26 | -$0.14 | -$0.37 | -164.29% | $29.00K | $40.00K | $6.62M | 16450.00% | 08/05/2021 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.23 | -$0.14 | -$0.40 | -185.71% | $30.00K | $40.00K | $914.00K | 2185.00% | 05/06/2021 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.29 | -$0.14 | -$0.05 | 64.29% | $29.00K | $40.00K | $50.03M | 124975.00% | 02/24/2021 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.21 | -$0.15 | -$0.28 | -86.67% | $230.00K | $50.00K | $29.00K | -42.00% | 11/10/2020 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.17 | -$0.14 | -$0.26 | -85.71% | $29.00K | $40.00K | $29.00K | -27.50% | 08/11/2020 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.14 | -$0.15 | -$0.15 | 0.00% | $30.00K | $50.00K | $30.00K | -40.00% | 05/14/2020 | Get Alert |
Aurinia Pharmaceuticals (AUPH) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $0.01 | $-0.02 | 150.0 % |
| Q3 | 2024-11-07 | $0.10 | $0.01 | 900.0 % |
| Q2 | 2024-08-01 | $0.01 | $0.01 | 0.00 % |
| Q1 | 2024-05-02 | $-0.03 | $-0.14 | 78.6 % |
Aurinia Pharmaceuticals (AUPH) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $59.87M | $59.94M | -0.12 % |
| Q3 | 2024-11-07 | $67.77M | $57.69M | 17.5 % |
| Q2 | 2024-08-01 | $57.19M | $55.05M | 3.89 % |
| Q1 | 2024-05-02 | $50.30M | $47.45M | 6.01 % |
FAQ
When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?
Aurinia Pharmaceuticals (AUPH) is scheduled to report earnings on May 1, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
What were the latest earnings per share (EPS) for Aurinia Pharmaceuticals (NASDAQ:AUPH)?
The Actual EPS was $0.01, which beat the estimate of $-0.02.
What were Aurinia Pharmaceuticals’s (NASDAQ:AUPH) revenues?
The Actual Revenue was $59.9M, which missed the estimate of $59.9M.
Browse earnings estimates, EPS, and revenue on all stocks.